Versant Venture Management as of March 31, 2022
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 10 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| CRISPR Therapeutics Common Shares (CRSP) | 31.2 | $31M | 499k | 62.77 | |
| Passage Bio Common Stock (PASG) | 15.3 | $15M | 5.0M | 3.10 | |
| Gritstone Oncology Common Stock (GRTS) | 14.6 | $15M | 3.6M | 4.12 | |
| Crinetics Pharmaceuticals Common Stock (CRNX) | 9.0 | $9.0M | 410k | 21.95 | |
| Akero Therapeutics Common Stock (AKRO) | 8.8 | $8.8M | 618k | 14.19 | |
| Minerva Surgical Common Stock | 7.5 | $7.5M | 1.7M | 4.50 | |
| Adverum Biotechnologies Common Stock | 6.6 | $6.6M | 5.1M | 1.31 | |
| Aligos Therapeutics Common Stock (ALGS) | 5.0 | $5.0M | 2.3M | 2.15 | |
| CymaBay Therapeutics Common Stock | 1.7 | $1.7M | 544k | 3.11 | |
| Clovis Oncology Common Stock | 0.2 | $206k | 102k | 2.02 |
